Journal of Practical Hepatology ›› 2023, Vol. 26 ›› Issue (1): 11-14.doi: 10.3969/j.issn.1672-5069.2023.01.004

• Hepatitis in vitro, in mice and in rats • Previous Articles     Next Articles

Effect of exosomes derived from mesenchymal stem cells on the proliferation and activation of hepatic stellate cells in vitro

Sun Donglei, Guo Jinbo, Wang Dandan, et al   

  1. Department of Gastroenterology, Second Hospital Affiliated to Hebei Medical University, Shijiazhuang 050000, Hebei Province, China
  • Received:2022-06-15 Online:2023-01-10 Published:2023-02-07

Abstract: Objective The purpose of this experiment was to investigate the effect of mesenchymal stem cells (MSC)-derived exosomes (MSCs-Exo) on the proliferation and activation of human hepatic stellate cells, e.g. LX-2 cells. Methods The MSCs-Exo were purchased and identified by electron microscopy observation and NanoFCM measurement. The LX-2 cells were stimulated with transforming growth factor-β1 (TGF-β1) at 5 μg/L, 10 μg/L and 20 μg/L concentration, and the α-SMA and COL1A1 mRNA and their proteins were detected by RT-PCR and Western blot. The activated LX-2 cells were intervened by MSCs-Exo at 50 μg/mL, 100 μg/mL at 200 μg/mL for 24 h. The LX-2 cell proliferation was detected by MTT assay. Results The morphological appearance and the particle sizes of MSCs-Exo revealed by transmission electron microscopy and NanoFCM accorded with requirement, and the MSCs-Exo positive marker proteins, CD9 and CD63 were positive, with GM130 protein negative; the α-SMA and COL1A1 mRNA and their protein expression in activated LX-2 cells by TGF-β1 stimulation were significantly increased and positively correlated with TGF-β1 concentration; the α-SMA and COL1A1 mRNA level and their protein expression were highest when the TGF-β1 induction at concentration of 20 μg/L; in the MSCs-Exo-100 and MSCs-Exo-200-intervened activated LX-2 cells, the proliferation viability of cells were significantly reduced compared with in the control (all P<0.0001); the α-SMA and COL1A1 mRNA and their protein expression in TGF-β1-activated LX-2 cells with different concentrations of MSCs-Exo intervention, e.g. at 50 μg/mL, 100 μg/mL and 200 μg/mL, were significantly decreased compared with in the control (P<0.001); the proliferation activities of LX-2 cells intervened by MSCs-Exo-100 and MSCs-Exo-200 were significantly decreased compared to that in the control cells (P<0.0001). Conclusion The MSCs-Exo could inhibit TGF-β1-induced proliferation and activation of LX-2 cells in vitro, and needs further investigation.

Key words: LX-2 cell, Mesenchymal stem cells-derived exosomes, Transforming growth factor-β1, Cell proliferation, Activation, In vitro